Effects of topiramate.
Kruszewski
Stefan P
SP
Klotz
Steven G
SG
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000188:drug therapy* / Q000523:psychology; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D017470:Receptors, Glutamate / Q000187:drug effects; D012107:Research Design / Q000592:standards; D000077236:Topiramate; D016896:Treatment Outcome
D000927:Anticonvulsants; D017470:Receptors, Glutamate; D000077236:Topiramate; D005632:Fructose